Meta-Analysis
Copyright ©The Author(s) 2015.
World J Meta-Anal. Feb 26, 2015; 3(1): 43-53
Published online Feb 26, 2015. doi: 10.13105/wjma.v3.i1.43
Table 2 Description of Included Studies
Ref.Sample size/AgeGenderInterventionComparisonKey outcomesAdverse
cancer type(SD/range)(F/M)groupgroupevents
On treatment studies/subgroups
Adamsen et al[22], 2009 Denmarkn = 117 Mixed Cancer Groups47.2 (± 6.7) yrF: 78 M: 39Aerobic Training with High-intensity Intervals + Resistance Exercise + Relaxation + MassageUsual care: allowed to freely increase physical activityEstimated VO2maxSeizure (n = 1)
Courneya et al[26], 2007 Canadan = 133 Breast Cancer49 yr (26-78)F: 133Aerobic TrainingUsual care: continue usual activitiesVO2peak QoL: FACT-AnemiaHypotension (n = 1) Dizziness (n = 1)
1Courneya et al[27], 2009b Canadan = 54 NHL, HL253.2 yr (18-80)2F: 50 M: 72Aerobic Training with High-intensity IntervalsUsual Care: continue usual activitiesVO2peak QoL: FACT-B/Ac/AnBack (n = 1), hip (n = 1) and knee (n = 1) pain
Hornsby et al[29], 2013 United Statesn = 20 Breast Cancer51 (± 6) yrF: 10Aerobic Training with High-intensity IntervalsControl: Continue usual exercise levelsVO2peak FACT-B Adverse EventsLeg pain (n = 1)
Hwang et al[30], 2012 Taiwann = 24 Lung61 (± 6.3)F: 12 M: 12Aerobic TrainingUsual Care: general patient educationVO2peak QoL: EORTCNot reported
Jarden et al[31], 2009 Denmarkn = 42 Mixed Cancer Groups39.1 (12.2)F: 16 M: 26Aerobic Training + Resistance Exercise + FlexibilityUsual CareEstimated VO2max QoL: EORTC, FACT-AnNone
Kim et al[33], 2006 United Statesn = 41 Breast Cancer51.3 (6.7) yrF: 41Aerobic TrainingWaitlist ControlVO2peakNot reported
MacVicar et al[34], 1989 United Statesn = 34 Breast Cancer45.4 (10.2) yrF: 34Aerobic Training with High-intensity IntervalsControl: Continue normal activitiesVO2max L/minNot reported
Segal et al[38], 2001 Canadan = 66 Breast Cancer51 (± 8.7) yrF: 66Aerobic TrainingControl group encouraged to exerciseEstimated VO2max QoL: SF36Not reported
Off treatment studies/comparisons
Broderick et al[23], 2013 Irelandn = 43 Mixed Cancer Groups52.3 (8.3) yrF: 37 M: 6Aerobic trainingUsual CareEstimated VO2max QoL: FACT-G, SF36Not reported
Burnham et al[24], 2000 United Statesn = 18 Mixed Cancer Groups54.2 (8.1) yrF: 15 M: 3Aerobic trainingControlVO2peak QoL: LASANot reported
Courneya et al[25], 2003 Canadan = 50 Breast Cancer59 (± 6) yrF: 54Aerobic trainingNo exerciseVO2peak QoL: FACT-BreastLymphedema (n = 3) Gynecological complication (n = 1)
1Courneya et al[27], 2009a Canadan = 68 NHL, HL2As per Courneya, 2009b2As per Courneya, 2009b2As per Courneya, 2009b2As per Courneya, 2009b2As per Courneya, 2009b2As per Courneya, 2009b
Herrero et al[28], 2005 Spainn = 16 Breast Cancer51 (10) yrF: 16Aerobic plus Resistance TrainingNo ExerciseVO2peak QoL: EORTCNot reported
Kaibori et al[32], 2013 Japann = 51 Liver Cancer68 (9.1) yrF: 15 M: 36Aerobic Training + Stretching + Diet InterventionDiet InterventionVO2peakNot reported
Mehnert et al[35], 2011 Germanyn = 58 Breast Cancer53 (7.4) yrF: 58Aerobic Training + Physiotherapeutic Exercises + RelaxationWaitlist ControlVO2max QoL: BIQNot reported
Naumann et al[36], 2011 Australian = 21 Breast Cancer49 (10) yrF: 21Aerobic Training + Resistance Exercise + FlexibilityUsual CareEstimated VO2max QoL: FACT-BNot reported
Rahnama et al[37], 2010 Irann = 29 Breast Cancer58.3 (6.3) yrF: 29Aerobic Training + Resistance ExerciseNo exerciseEstimated VO2maxNot reported
Thorsen et al[39], 2005 Norwayn = 111 Mixed Cancer Groups39 (8.4) yrF: 36 M: 75Aerobic Training + Resistance ExerciseUsual CareEstimated VO2max QoL: EORTCNot reported